ENTITY
SK Biopharmaceuticals

SK Biopharmaceuticals (326030 KS)

120
Analysis
Health CareSouth Korea
SK Biopharmaceuticals Co., Ltd. researches and develops new drugs. The Company develops and markets brain disorders treatment drugs, central nervous system disorders treatment drugs, and other products. SK Biopharmaceuticals markets its products worldwide.
more
Refresh
Presentation Icon
No presentations found
We’ll display presentations we find for SK Biopharmaceuticals here
x